Kiromic Biopharma, Inc.·4

Jan 6, 5:00 PM ET

Rotino Gianluca 4

4 · Kiromic Biopharma, Inc. · Filed Jan 6, 2021

Insider Transaction Report

Form 4
Period: 2020-12-18
Rotino Gianluca
DirectorCSIO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-12-18+4,4234,423 total
    Exercise: $8.14Exp: 2030-12-17Common Stock (4,423 underlying)
Footnotes (1)
  • [F1]4,054 of the shares subject to the option will vest on October 16, 2021 and the remaining 369 shares subject to the option will vest on November 16, 2021, subject to continuing service.

Documents

1 file
  • 4
    a4.xmlPrimary

    4